Integrity Bio, LakePharma become Curia
Curia (formerly AMRI) announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand. Read More
FDNA publishes breakthrough in AI for rare disease ID
FDNA has published breakthrough findings in Nature Genetics on February 10 that involve the use of facial analysis as a tool to help detect rare genetic disorders. The study showed that FDNA's artificial intelligence (AI) technology could accelerate the clinical diagnosis of patients with ultrarare disorders and facial dysmorphism, as well as enable the definition of new syndromes. Read More
Regen BioPharma initiates mRNA anticancer vaccine technology
Regen BioPharma is embarking on a development program to commercialize its modified mRNA anticancer vaccine targeting the survivin protein. Regen said it will design and conduct experiments that will form the initial series of preclinical studies required as part of a U.S. Food and Drug Administration investigational new drug submission. Read More
Asymchem acquires Snapdragon Chemistry
Asymchem Laboratories will acquire Snapdragon Chemistry for $57.94 million. The addition will significantly expand Asymchem's footprint in the U.S., offering customers a seamless path from preclinical process R&D to commercial current good manufacturing practices production. Read More
Purigen Biosystems signs exclusive distribution agreement with Bonsai Lab
Purigen Biosystems signed a new distribution agreement with Bonsai Lab. Bonsai Lab has the exclusive rights to distribute, service, and support Purigen's Ionic Purification System and microfluidic kits in Portugal and Spain. Read More
GenScript opens state-of-the-art manufacturing facility in Singapore
GenScript Biotech has opened a 30,000-sq-ft facility for highly automated protein and gene preparation services. The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high-quality, fast turnaround on products required for new vaccines, as well as therapeutics development and innovations in life sciences. Read More
Arkuda Therapeutics raises $64M in series B financing round
Arkuda Therapeutics completed a $64 million series B financing round. The company plans to use the funds to support investigational new drug-enabling studies and expand its pipeline of programs targeting lysosomal dysfunction, a key driver of many neurodegenerative diseases. Read More
CytoReason and Pfizer extend collaboration
CytoReason has extended its collaboration agreement with Pfizer to investigate challenging biological questions that potentially inform the development of new therapies for the benefit of patients. Read More
BioMade grants $12.1M to 16 bioindustrial manufacturing projects
The Bioindustrial Manufacturing and Design Ecosystem (BioMade) is granting $5.8 million in federal funds to 16 innovative projects aimed at accelerating bioindustrial manufacturing knowledge, capabilities, and the workforce in the U.S. Read More
Hummingbird Bioscience reveals potential of HMBD-002
Hummingbird Bioscience published preclinical data for HMBD-002, a novel antiVISTA antibody therapeutic, in the Journal for ImmunoTherapy of Cancer on February 7. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
